Sheikh, I. N., Alqahtani, S., Okeleji, O., Brown, B. D., Ragoonanan, D., Waseemuddin, M., … Mahadeo, K. M. (2026). Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes. Bone Marrow Transplant, 61(2), 241–244. https://doi.org/10.1038/s41409-025-02776-y

Sheikh, Irtiza N., Shaikha Alqahtani, Olayinka Okeleji, Brandon D. Brown, Dristhi Ragoonanan, Mohammed Waseemuddin, Basirat Shoberu, et al. “Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes.” Bone Marrow Transplant 61, no. 2 (February 2026): 241–44. https://doi.org/10.1038/s41409-025-02776-y.

Sheikh IN, Alqahtani S, Okeleji O, Brown BD, Ragoonanan D, Waseemuddin M, et al. Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes. Bone Marrow Transplant. 2026 Feb;61(2):241–4.

Sheikh, Irtiza N., et al. “Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes.” Bone Marrow Transplant, vol. 61, no. 2, Feb. 2026, pp. 241–44. Pubmed, doi:10.1038/s41409-025-02776-y.

Sheikh IN, Alqahtani S, Okeleji O, Brown BD, Ragoonanan D, Waseemuddin M, Shoberu B, Kawedia J, Khazal SJ, Connors J, Petropoulos D, Tewari P, Bonfim C, Driscoll TA, DePriest BP, Mahadeo KM. Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes. Bone Marrow Transplant. 2026 Feb;61(2):241–244.